I am as optimistic as anyone on the eventual value of BIOD, but I do not expect any partnership news regarding Viaject before approval. The company has already said this too. There might be some partnership activity on the early stage products at any point, but not Viaject. And I don't expect anything new to be said on the conf call regarding partnerships. Companies almost never talk about anything specific regarding partnership talks until the deal is signed. I'm just sticking with the facts on BIOD- which lead me to say it is a screaming buy here though.